Yonsei Med J.  2014 Mar;55(2):449-458.

Influence of Bacterial Presence on Biofilm Formation of Candida albicans

Affiliations
  • 1Department of Microbiology, Yonsei University Wonju College of Medicine, Wonju, Korea. leekh@yonsei.ac.kr
  • 2Department of Obsterics and Gynecology, Yonsei University Wonju College of Medicine, Wonju, Korea.

Abstract

PURPOSE
Candida albicans is an opportunistic pathogen that is commonly found in human microflora. Biofilm formation (BF) is known as a major virulence factor of C. albicans. The aim of this study was to examine the influence of bacterial presence on biofilm formation of C. albicans.
MATERIALS AND METHODS
The BF of Candida was investigated when it was co-cultured with C. albicans (C. albicans 53, a yeast with a low BF ability, and C. albicans 163, a yeast with high BF ability) and bacteria. BF was assessed with XTT reduction assay. A scanning electron microscope was used to determine the structure of the biofilm, and real-time reverse transcriptase polymerase chain reaction was used to amplify and quantify hyphae-associated genes.
RESULTS
Co-culturing with two different types of bacteria increased the BF value. Co-culturing with C. albicans 53 and 163 also increased the BF value compared to the value that was obtained when the C. albicans was cultured individually. However, co-culturing with bacteria decreased the BF value of C. albicans, and the BF of C. albicans 163 was markedly inhibited. The expression of adherence and morphology transition related genes were significantly inhibited by co-culturing with live bacteria.
CONCLUSION
Bacteria have a negative effect on the formation of biofilm by C. albicans. This mechanism is the result of the suppression of genes associated with the hyphae transition of C. albicans, and bacteria particles physically affected the biofilm architecture and biofilm formation.

Keyword

Candida albicans; biofilm; co-culture; bacteria

MeSH Terms

Architecture as Topic
Bacteria
Biofilms*
Candida albicans*
Candida*
Coculture Techniques
Humans
Hyphae
Methods
Reverse Transcriptase Polymerase Chain Reaction
Virulence
Yeasts

Figure

  • Fig. 1 Biofilm formation was monitored for the different types of bacteria. Suspensions of each type of bacteria (OD. 0.2) were added to wells in a 96-well microtiter plate. The plate was incubated for 1.5 h at 37℃ in an orbital shaker at 75 rpm. After the initial adhesion phase, the cells suspensions were aspirated, and each well was washed twice with PBS to remove loosely adherent cells. Each well had 200 µL of fresh TSB added to promote biofilm growth and was incubated at 37℃ for 72 h. The amount of biofilm formed was measured using the XTT assay. Absorbance at 490 nm was measured following a 3 h incubation with XTT (1 mg/mL)-Menadion (0.4 mM). Presented values are mean±SD of three independent experiments. PBS, phosphate-buffered saline; TSB, tryptic soy broth.

  • Fig. 2 The effect of co-culture of bacteria and C. albicans on biofilm formation. (A) Biofilm formation ability of C. albicans 53 was low. (B) Biofilm formation ability of C. albicans 163 was high. C. albicans (OD. 0.2) was cultured alone. Suspensions of bacteria (OD. 0.1) and C. albicans (OD. 0.1) were added to wells in a 96-well microtiter plate. The plate was incubated for 1.5 h at 37℃ in an orbital shaker at 75 rpm. After the initial adhesion phase, the cells suspensions were aspirated, and each well was washed twice with PBS to remove loosely adherent cells. The plate was incubated for 72 h at 37℃ in an orbital shaker at 75 rpm. The amount of biofilm formed was measured using the XTT assay. Absorbance at 490 nm was measured following incubation with XTT (1 mg/mL)Menadion (0.4 mM) for 3 h. Open bar: live C. albicans+live bacteria, black bar: C. albicans alone. Presented values are mean±SD of three independent experiments. p<0.05 was considered statistically significant. *p<0.05, **p<0.01. PBS, phosphate-buffered saline.

  • Fig. 3 The effect of the presence of dead bacteria on biofilm formation of C. albicans. (A) Biofilm formation ability of C. albicans 53 was low. (B) Biofilm formation ability of C. albicans 163 was high. The bacteria were killed by an incubation of 100℃ for 30 min. Suspensions of bacteria (OD. 0.1) and C. albicans (OD. 0.1) were added to wells in a 96-well microtiter plate. The plate was incubated for 1.5 h at 37℃ in an orbital shaker at 75 rpm. After the initial adhesion phase, the cells suspensions were aspirated, and each well was washed twice with PBS to remove loosely adherent cells. The plate was incubated for 72 h at 37℃ in an orbital shaker at 75 rpm. The amount of biofilm formed was measured using the XTT assay. Absorbance at 490 nm was measured following incubation with XTT (1 mg/mL)-Menadion (0.4 mM) for 3 h. Open bar: live C. albicans+dead bacteria, black bar: live C. albicans alone. Presented values are mean±SD of three independent experiments. p<0.05 was considered statistically significant. *p<0.05, **p<0.01. PBS, phosphate-buffered saline.

  • Fig. 4 The effect of the presence of dead C. albicans on the biofilm formation of bacteria. (A) Biofilm formation ability of C. albicans 53 was low. (B) Biofilm formation ability of C. albicans 163 was high. The C. albicans isolates were killed by incubation at 100℃ for 30 min. Suspensions of bacteria (OD. 0.1) and C. albicans (OD. 0.1) were added to wells in a 96-well microtiter plate. The plate was incubated for 1.5 h at 37℃ in an orbital shaker at 75 rpm. After the initial adhesion phase, the cells suspensions were aspirated, and each well was washed twice with PBS to remove loosely adherent cells. The plate was incubated for 72 h at 37℃ in an orbital shaker at 75 rpm. The amount of biofilm formed was measured using the XTT assay. The absorbance at 490 nm was measured following a 3 h incubation with XTT (1 mg/mL)-Menadion (0.4 mM). Open bar: dead C. albicans+live bacteria, black bar: live bacteria alone. Presented values are mean±SD of three independent experiments. PBS, phosphate-buffered saline.

  • Fig. 5 Scanning electron micrograph images of monospecies (C. albicans or E. coli) and dual species (C. albicans and E. coli). (A) C. albicans 163 monospecies biofilm. (B) Live C. albicans 163 and live E. coli dual species biofilm. (C) Live C. albicans 163 and dead E. coli dual species biofilm. Magnifications are 500×(scale bar; 20 µm) and 4000×(scale bar; 2 µm), respectively.

  • Fig. 6 Relative quantitation of hyphae-specific genes (Als3, Ece1, Hwp1, Sap5) expression. The expressions of mRNA were evaluated via quantitative real-time reverse transcriptase polymerase chain reaction in C. albicans 163 biofilm formation. Data represent the mean±SD of three separate cultures. p<0.05 was considered statistically significant. *p<0.05, **p<0.01.

  • Fig. 7 Effect of live bacteria presence on expression of hyphae related gene on C. albicans. Relative quantitation of Als3 (A), Ece1 (B), Hwp1 (C), and Sap5 (D) gene expression was evaluated. C. albicans 163 cells were co-cultured with bacteria for 24 h and the target genes were determined by quantitative real-time reverse transcriptase polymerase chain reaction. Housekeeping gene Act1 and Pma1 were used for normalization. The data represent the average and standard deviation of three separate cultures. p<0.05 was considered statistically significant. *p<0.05, **p<0.01.


Reference

1. Samaranayake LP. Essential microbiology for dentistry. 3rd ed. New York: Churchill Livingstone Elsevier;2006.
2. Lynch AS, Robertson GT. Bacterial and fungal biofilm infections. Annu Rev Med. 2008; 59:415–428.
Article
3. Ramage G, Martínez JP, López-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 2006; 6:979–986.
Article
4. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001; 183:5385–5394.
Article
5. Nett J, Andes D. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr Opin Microbiol. 2006; 9:340–345.
Article
6. Baillie GS, Douglas LJ. Role of dimorphism in the development of Candida albicans biofilms. J Med Microbiol. 1999; 48:671–679.
Article
7. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev. 2004; 17:255–267.
8. Hansen SK, Rainey PB, Haagensen JA, Molin S. Evolution of species interactions in a biofilm community. Nature. 2007; 445:533–536.
Article
9. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005; 43:5721–5732.
Article
10. Manson JM, Rauch M, Gilmore MS. The commensal microbiology of the gastrointestinal tract. Adv Exp Med Biol. 2008; 635:15–28.
Article
11. Mclean RJC, Banes MB, McGowin CL, Aron GM. Methods of studying biofilms. In : Ghannoum MA, O'Toole GA, editors. Microbial biofilms. Washington, DC: ASM Press;2004. p. 379–413.
12. Tolker-Nielsen T, Hansen SK. Microbial interaction in mixed-species biofilms. In : Ghannoum MA, O'Toole GA, editors. Microbial biofilms. Washington, DC: ASM Press;2004. p. 206–221.
13. Shirtliff ME, Peters BM, Jabra-Rizk MA. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol Lett. 2009; 299:1–8.
14. Ramage G, Vandewalle K, Wickes BL, López-Ribot JL. Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol. 2001; 18:163–170.
15. Thein ZM, Seneviratne CJ, Samaranayake YH, Samaranayake LP. Community lifestyle of Candida in mixed biofilms: a mini review. Mycoses. 2009; 52:467–475.
16. El-Azizi MA, Starks SE, Khardori N. Interactions of Candida albicans with other Candida spp. and bacteria in the biofilms. J Appl Microbiol. 2004; 96:1067–1073.
Article
17. Uppuluri P, Dinakaran H, Thomas DP, Chaturvedi AK, Lopez-Ribot JL. Characteristics of Candida albicans biofilms grown in a synthetic urine medium. J Clin Microbiol. 2009; 47:4078–4083.
Article
18. Nailis H, Kucharíková S, Ricicová M, Van Dijck P, Deforce D, Nelis H, et al. Real-time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and -independent gene expression. BMC Microbiol. 2010; 10:114.
Article
19. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs. 2005; 28:1062–1068.
Article
20. Li X, Yan Z, Xu J. Quantitative variation of biofilms among strains in natural populations of Candida albicans. Microbiology. 2003; 149(Pt 2):353–362.
Article
21. Hogan DA, Kolter R. Pseudomonas-Candida interactions: an ecological role for virulence factors. Science. 2002; 296:2229–2232.
Article
22. Hogan DA, Vik A, Kolter R. A Pseudomonas aeruginosa quorum sensing molecule influences Candida albicans morphology. Mol Microbiol. 2004; 54:1212–1223.
Article
23. Bandara HM, Yau JY, Watt RM, Jin LJ, Samaranayake LP. Escherichia coli and its lipopolysaccharide modulate in vitro Candida biofilm formation. J Med Microbiol. 2009; 58(Pt 12):1623–1631.
Article
24. Staab JF, Bradway SD, Fidel PL, Sundstrom P. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science. 1999; 283:1535–1538.
Article
25. Hoyer LL. The ALS gene family of Candida albicans. Trends Microbiol. 2001; 9:176–180.
Article
26. Birse CE, Irwin MY, Fonzi WA, Sypherd PS. Cloning and characterization of ECE1, a gene expressed in association with cell elongation of the dimorphic pathogen Candida albicans. Infect Immun. 1993; 61:3648–3655.
Article
27. Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev. 2003; 67:400–428.
Article
28. Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev. 2003; 67:400–428.
Article
29. Armbruster CE, Hodges SA, Mobley HL. Initiation of swarming motility by Proteus mirabilis occurs in response to specific cues present in urine and requires excess L-glutamine. J Bacteriol. 2013; 195:1305–1319.
Article
Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr